SHIRLEY ZENG: Open Payments
NPI 1114376290 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$665 in 29 payments from 13 companies in 2025. Trend: 2023 $444 · 2024 $620 · 2025 $665
Food & beverage: $665
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 11 | $279 |
| CIVCO Medical Instruments | 2 | $77 |
| Novartis Pharmaceuticals Corporation | 2 | $49 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $42 |
| UROGEN PHARMA, INC. | 2 | $38 |
| Alnylam Pharmaceuticals Inc. | 1 | $37 |
| Travere Therapeutics, Inc. | 3 | $36 |
| Astellas Pharma US Inc | 1 | $25 |
| ABBVIE INC. | 1 | $18 |
| COLOPLAST CORP | 1 | $17 |
Products named: GEMTESA, JOURNAVX, OXLUMO, Fabhalta, Xtandi, ORGOVYX, BOTOX, Luja Coude.
Industry payments across NY — which companies pay providers there.
